{"id":"https://openalex.org/W155640193","doi":null,"title":"ORG 3770 VS Amitripty in the continuation treatmen of depression:: A placebo controlled trial.","display_name":"ORG 3770 VS Amitripty in the continuation treatmen of depression:: A placebo controlled trial.","publication_year":1996,"publication_date":"1996-01-01","ids":{"openalex":"https://openalex.org/W155640193","mag":"155640193"},"language":"en","primary_location":{"id":"mag:155640193","doi":null,"is_oa":false,"landing_page_url":"https://dialnet.unirioja.es/servlet/articulo?codigo=3114086","pdf_url":null,"source":{"id":"https://openalex.org/S26676506","display_name":"The European Journal of Psychiatry","issn_l":"0213-6163","issn":["0213-6163"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","norway-1","poland-40","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"The European Journal of Psychiatry","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090528070","display_name":"J. Douglas Bremner","orcid":"https://orcid.org/0000-0003-1633-6433","observed_orcids":["https://orcid.org/0000-0003-1633-6433"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"J. Douglas Bremner","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1633-6433","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5090528070"],"corresponding_institution_ids":[],"apc_list":{"value":1910,"currency":"USD","value_usd":1910},"apc_paid":null,"fwci":1.0702,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.75656643,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"10","issue":"1","first_page":"5","last_page":"15"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13118","display_name":"Psychological Treatments and Disorders","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/amitriptyline","display_name":"amitriptyline","score":0.9010000228881836},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.6069999933242798},{"id":"https://openalex.org/keywords/continuation-therapy","display_name":"continuation treatment","score":0.9350000023841858},{"id":"https://openalex.org/keywords/tricyclic-antidepressants","display_name":"tricyclic antidepressants","score":0.9240000247955322},{"id":"https://openalex.org/keywords/trazodone","display_name":"trazodone","score":0.6079999804496765},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.4560000002384186},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.7049999833106995},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.4959999918937683},{"id":"https://openalex.org/keywords/hamilton-depression-rating-scale","display_name":"Hamilton Depression Rating Scale","score":0.6570000052452087},{"id":"https://openalex.org/keywords/clinical-global-improvement","display_name":"Clinical Global Improvement","score":0.5770000219345093}],"concepts":[{"id":"https://openalex.org/C2777198177","wikidata":"https://www.wikidata.org/wiki/Q3765927","display_name":"Hamd","level":3,"score":0.8549234867095947},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.8458043336868286},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.5697357654571533},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5308493375778198},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5089783668518066},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4917896091938019},{"id":"https://openalex.org/C2780216858","wikidata":"https://www.wikidata.org/wiki/Q58397","display_name":"Amitriptyline","level":2,"score":0.4719010293483734},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4712774157524109},{"id":"https://openalex.org/C3017583242","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Placebo group","level":4,"score":0.4678210914134979},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.4395727813243866},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.40851134061813354},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3901873826980591},{"id":"https://openalex.org/C3018023364","wikidata":"https://www.wikidata.org/wiki/Q425265","display_name":"Significant difference","level":2,"score":0.09275209903717041},{"id":"https://openalex.org/C2779144063","wikidata":"https://www.wikidata.org/wiki/Q338924","display_name":"Amygdala","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:155640193","doi":null,"is_oa":false,"landing_page_url":"https://dialnet.unirioja.es/servlet/articulo?codigo=3114086","pdf_url":null,"source":{"id":"https://openalex.org/S26676506","display_name":"The European Journal of Psychiatry","issn_l":"0213-6163","issn":["0213-6163"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","norway-1","poland-40","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"The European Journal of Psychiatry","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1989017915","https://openalex.org/W2405100977","https://openalex.org/W2135143043","https://openalex.org/W2113784982","https://openalex.org/W2004821635","https://openalex.org/W2149554797","https://openalex.org/W2418515635","https://openalex.org/W2069332142","https://openalex.org/W2147391344","https://openalex.org/W2051807732"],"abstract_inverted_index":{"One":[0],"hundred":[1],"and":[2,16,73,141],"eighteen":[3],"patients":[4,83,107,129,149],"who":[5],"participated":[6],"in":[7,43,52,146,151],"two":[8],"short-term":[9],"double-blind":[10],"comparisons":[11],"of":[12,34,75,118],"Org":[13,57,81,136],"3770,":[14],"amitriptyline":[15,153],"placebo":[17,45,120],"were":[18,50,144],"subsequently":[19],"included":[20],"into":[21],"a":[22],"20-week":[23],"extension":[24,31],"trial.":[25,32],"Data":[26],"is":[27],"presented":[28],"from":[29],"the":[30,37,44,61,66,91,94,119,125,152],"Lack":[33],"efficacy":[35],"was":[36,138],"main":[38],"reason":[39],"for":[40],"patient":[41],"withdrawal":[42],"group,":[46,93],"while":[47],"adverse":[48,142],"effects":[49,143],"so":[51],"both":[53],"active-treatment":[54],"groups.":[55],"The":[56,114],"3770-treated":[58],"group":[59,68,121],"had":[60,84],"most":[62],"favorable":[63],"outcome":[64],":":[65],"mean":[67,95,115],"HAMD":[69,87,96,111,116,133],"score":[70,77,88,97,112,117,134],"remained":[71,122],"\u22647":[72,101],"CGI-Severity":[74],"Illness":[76],"\u22642.":[78],"Only":[79],"2.4%":[80],"3770":[82,137],"an":[85,109,131],"endpoint":[86,110,132],"\u226516.":[89,113,135],"In":[90],"amitriptyline-treated":[92],"stabilized":[98],"at":[99,102],"level":[100],"week":[103],"12,":[104],"with":[105,127],"10.4%":[106],"having":[108,130],"\u22657":[123],"throughout":[124],"trial,":[126],"23.0%":[128],"tolerated":[139],"well,":[140],"present":[145],"substantially":[147],"fewer":[148],"than":[150],"group.":[154]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}